CipherBio Weekly Digest: Week of Jan 13 – 19 2022
This week CipherBio added $5.74B in deals and an incredible 91 new life science companies to our platform.
Featured Top Investments
From seed to acquisition it happened. Avaneer Health announces $50M in Seed funding. In Series A, Ceptur Therapeutics (Silagene) gets $75 Million. And Iterative Scopes announces $150M / Series B to advance AI-driven precision medicine for gastroenterology. Wheel raises $150M in Series C led by Lightspeed Ventures, Tiger Global and others.
Vista Equity invests $300M / Series E in TigerConnect, a digital health/AI company. Center for Breakthrough Medicine, an innovative cell and gene therapy company, received $350 million in equity financing from South Korean SK Inc. (KRX: 034730). Leader in diagnostics testing, Sema4 acquired GeneDx, a global leader in genetic and genomic testing, for $623M.
|Ceptur Therapeutics (Silagene)||Series A||$75M|
|Iterative Scopes||Series B||$150M|
|Center for Breakthrough Medicine||Equity||$350M|
Just recently Andreessen Horowitz raised $9B in new capital for venture, growth, bio funds. This week a London-based VC firm, Entree Capital raised $300M in early stage fund IV from undisclosed investors. And Emmertech closes the $60M fund to help fuel Canada as a global agtech leader.
Most Active Investors
The VC firms with notable investments this week are SK Inc., Vista Equity Partners, Prime Movers Lab, Lightrock, Lightspeed Ventures, venBio Partners which participated in rounds totaling over $1 Billion.
91 New Life Science Companies
We added 91 new life science companies this week alone and the list is growing.
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.